Holdings - Galloway Ltd

Galloway is an investment group with a diverse portfolio of quoted and unquoted investments. Galloway invests in organisations (and individuals) that demonstrate the potential to take advantage of business, product and market opportunities. This can equally be an old company seeking to exploit a new market opportunity or an individual with a brand new business proposal.

Denham Eke is Director & Company Secretary

Here is a selection of companies that Galloway has invested in:



Bodas was conceived by Helena Boas and Donella Tarantelli in September 2000. Their concept was to create a new brand of high quality, everyday women's underwear in beautiful but practical fabrics. Bodas lingerie looks and feels like a luxury but is affordable and made for wearing every day. The Bodas mission has become one of designing underwear which looks and feels like a luxury, is incredibly comfortable and has exceptional fit, but which is also practical and affordable- always striking a balance between fashion and tradition.



General Mikhail T Kalashnikov, inventor of the AK-47, licensed his name to allow the launch of this interesting vodka brand. The company's mission is to supply, promote and internationalise quality Russian Vodka - an integral part of Russian culture, that should always be drunk in the spirit of friendship.



Steribottle is a disposable, affordable single-use feeding bottle. It's made of safe plastic, and it comes complete with a special teat all pre-sterilised and ready to use. The company was formed over a decade ago and the product is widely distributed in the UK. It has just invested more than £3m in the completion of a new state-of-the-art manufacturing facility near Nottingham. Soon to expand into the USA and Asia, Steribottle will soon be helping babies feed safely on the move and at home across the World.



Miraculins Inc. is dedicated to the discovery and development of diagnostics and therapeutic targets for selected cancers. Currently, Miraculins is focused on developing improved diagnostics for cancers of the digestive, genital and urinary systems, initially with a focus on prostate cancer. The medical community is in need of minimally invasive diagnostics that offer a quick and accurate window into a patient's health.